NCT06562881

Brief Summary

The goal of this study is to address surgical health equity in historically marginalized participants with primary hyperparathyroidism (PHPT). The main questions that this study aims to answer are, how does patient navigation impact:

  • The proportion of PHPT participants undergo parathyroidectomy?
  • The proportion of PHPT participants who complete surgical consultation?
  • Time to surgical consultation?
  • Time to surgery?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
May 2026Dec 2026

First Submitted

Initial submission to the registry

August 12, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 20, 2024

Completed
1.7 years until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

August 12, 2024

Last Update Submit

March 17, 2026

Conditions

Keywords

ParathyroidectomyBarriers and Challenges to Surgical Health Equity

Outcome Measures

Primary Outcomes (1)

  • Parathyroidectomy Surgical Outcome

    The primary outcome will be the proportion of patients who undergo parathyroidectomy

    Within 12 months

Secondary Outcomes (8)

  • Completion of Consultation

    Through study completion, an average of 1 year after time of recruitment or surgery

  • Time to Consultation

    Through study completion, an average of 1 year after time of recruitment or surgery

  • Time to Surgery

    Through study completion, an average of 1 year after time of recruitment or surgery

  • Complications related to hyperparathyroidism

    Assessed at 6 and 12 months after recruitment or surgery in all groups

  • Parathyroidectomy complications

    Assessed at 6 and 12 months after recruitment or surgery in all groups

  • +3 more secondary outcomes

Study Arms (2)

Scheduling Navigation

EXPERIMENTAL

Participants will be assigned to a scheduler.

Other: Scheduling Navigation

Without Scheduling Navigation

ACTIVE COMPARATOR

Participants will not be assigned to a scheduler.

Other: Without Scheduling Navigation

Interventions

Patients will work with clinic staff in the usual fashion for their treatment for primary hyperparathyroidism. They will not be connected directly to a scheduler to help schedule a surgical consultation visit at time of recruitment. With our crossover design, if patients have not yet received surgical consultation after 3 months, they will be called and connected with a scheduler at that time. Participation does not guarantee or require surgery.

Without Scheduling Navigation

Participants will be connected to a scheduler to schedule a surgical consultation visit at time of recruitment. Participation does not guarantee or require surgery.

Scheduling Navigation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with PHPT and not yet had parathyroidectomy who meet criteria for surgical treatment of PHPT (osteoporosis, fragility fracture, or evidence of vertebral compression fracture on spine imaging, renal involvement \[renal stone, silent nephrolithiasis on renal imaging, nephrocalcinosis, hypercalciuria (24-hour urine calcium level 400 mg/dL) with increased stone risk, or impaired renal function (glomerular filtration rate 60 mL/min)\], calcium 1 mg/dL above upper limit of normal, age less than 50)
  • Qualify as a member of a racial or ethnic minority group (Black, Hispanic, Asian and Pacific Islander, Native American), lower socioeconomic neighborhoods (by zipcode), socially vulnerable (social determinants of health indicating financial strain, social vulnerability index in the top quartile 75%+ by zip code), or with underinsurance (Medicaid, Medicare, dual eligible, uninsured)

You may not qualify if:

  • Prior Parathyroidectomy
  • End-stage Renal Disease
  • Renal Transplant
  • Vitamin D Deficiency
  • Metastatic Disease
  • Familial Hypocalciuric Hypercalcemia
  • No Indication for Surgery
  • Unable/Unwilling to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

MeSH Terms

Conditions

Hyperparathyroidism, Primary

Condition Hierarchy (Ancestors)

HyperparathyroidismParathyroid DiseasesEndocrine System Diseases

Study Officials

  • Rachel Kelz, MD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Executive Vice Chair

Study Record Dates

First Submitted

August 12, 2024

First Posted

August 20, 2024

Study Start

May 1, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

March 19, 2026

Record last verified: 2026-03

Locations